Eyepoint Pharmaceuticals Inc (EYPT NASDAQ) stock market data APIs
$14.4128
0.24(1.7%)
as of April 14, 2026
Try our APIs with
free plan!
Eyepoint Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.
Prev. Close
14.4128
Open
14.6564
High
14.7164
Low
14.2174
52 wk Range
5.3-19.11
Market Cap
1 196 M
Shares Outstanding
83 432 K
Revenue
31 371 K
EPS
-0.81
Beta
1.907
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eyepoint Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eyepoint Pharmaceuticals Inc data using free add-ons & libraries
Get Eyepoint Pharmaceuticals Inc Fundamental Data
Eyepoint Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 31 371 K
- EBITDA: -241 124 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: -0.7477
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eyepoint Pharmaceuticals Inc News
New
Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?
Arvinas, Inc.ARVN shares soared 6.9% in the last trading session to close at $11.33. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...
EyePoint sues Ocular over claims related to lead asset
[Lawsuit Gavel] * EyePoint (EYPT [https://seekingalpha.com/symbol/EYPT]) has filed a lawsuit against Ocular Therapeutix (OCUL [https://seekingalpha.com/symbol/OCUL]) in a Massachusetts federal cour...
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug
March 20 (Reuters) - EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or misleading information about EyePoint and its lead experimental eye drug. The com...
RBC: Revolution, Xenon, Arrowhead among top takeover targets
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. About a dozen biotechnology companies currently stand...
Get Eyepoint Pharmaceuticals Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
